Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Silgan Holdings
SLGN
$4.48B
| $3.59M | 0.09% |
86,722
+27,583
| +47% | +$1.21M |
|
277
Kennametal
KMT
$2.28B
| $3.58M | 0.09% |
154,066
-55,423
| -26% | -$1.46M |
|
|
NEWR
278
DELISTED
New Relic, Inc.
NEWR
| $3.53M | 0.09% |
+70,570
| New | +$3.92M |
|
279
Okta
OKTA
$23.5B
| $3.5M | 0.09% |
38,741
-19,908
| -34% | -$2.15M |
|
|
SPWR
280
DELISTED
SunPower Corporation Common Stock
SPWR
| $3.48M | 0.09% |
220,306
+142,870
| +185% | +$2.57M |
|
281
Buckle
BKE
$2.26B
| $3.48M | 0.09% |
125,537
+1,750
| +1% | +$54.9K |
|
282
Charles River Laboratories
CRL
$14.1B
| $3.46M | 0.09% |
16,193
+3,727
| +30% | +$911K |
|
283
Devon Energy
DVN
$54B
| $3.44M | 0.09% |
+62,448
| New | +$4.08M |
|
284
Highwoods Properties
HIW
$3.46B
| $3.44M | 0.09% |
100,606
+15,054
| +18% | +$594K |
|
285
Woodward
WWD
$20.3B
| $3.42M | 0.09% |
36,933
+20,985
| +132% | +$2.18M |
|
286
First Industrial Realty Trust
FR
$8.34B
| $3.41M | 0.09% |
71,892
-16,974
| -19% | -$930K |
|
287
Atkore
ATKR
$3.16B
| $3.4M | 0.09% |
41,012
+34,880
| +569% | +$3.47M |
|
288
CALL
Bristol-Myers Squibb
BMY
$137B
| $3.4M | 0.09% |
44,200
+28,100
| +175% | +$2.14M |
|
289
Novavax
NVAX
$1.47B
| $3.4M | 0.09% |
66,151
+18,886
| +40% | +$978K |
|
290
Coty
COTY
$2.41B
| $3.39M | 0.09% |
422,703
+101,242
| +31% | +$760K |
|
291
Prudential Financial
PRU
$41.8B
| $3.37M | 0.09% |
+35,236
| New | +$3.73M |
|
292
Celanese
CE
$5.14B
| $3.36M | 0.09% |
28,590
-24,862
| -47% | -$3.57M |
|
293
Interparfums
IPAR
$3.7B
| $3.35M | 0.09% |
+45,910
| New | +$3.51M |
|
294
CF Industries
CF
$19.6B
| $3.33M | 0.09% |
38,800
-2,401
| -6% | -$233K |
|
295
Four Corners Property Trust
FCPT
$2.77B
| $3.31M | 0.09% |
124,549
-67,479
| -35% | -$1.84M |
|
296
CMS Energy
CMS
$21.4B
| $3.28M | 0.09% |
48,633
-205,543
| -81% | -$14.2M |
|
297
Tenet Healthcare
THC
$22.6B
| $3.27M | 0.09% |
+62,302
| New | +$4.34M |
|
298
Zebra Technologies
ZBRA
$17.4B
| $3.24M | 0.09% |
11,031
+6,261
| +131% | +$2.18M |
|
299
AdaptHealth
AHCO
$751M
| $3.24M | 0.09% |
179,526
+46,499
| +35% | +$755K |
|
300
Supernus Pharmaceuticals
SUPN
$2.67B
| $3.21M | 0.08% |
111,183
-16,894
| -13% | -$484K |
|
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.